Home/Filings/4/0001209191-22-050094
4//SEC Filing

Giberson Scott 4

Accession 0001209191-22-050094

CIK 0001833214other

Filed

Sep 14, 8:00 PM ET

Accepted

Sep 15, 5:00 PM ET

Size

5.7 KB

Accession

0001209191-22-050094

Insider Transaction Report

Form 4
Period: 2022-09-13
Transactions
  • Award

    Employee Stock Option (right to buy)

    2022-09-13+25,00025,000 total
    Exercise: $0.71Exp: 2032-09-13Common Stock (25,000 underlying)
Footnotes (2)
  • [F1]Represents options to purchase shares of common stock pursuant to the Company's 2021 Omnibus Equity Incentive Plan.
  • [F2]The shares underlying the option vest over a three-year period, vesting 1/36 monthly beginning with the month following the Reporting Person's commencement of service as a director (July 6, 2022). This represents the initial grant to the Reporting Person as a member of the Board of Directors.

Issuer

SAB Biotherapeutics, Inc.

CIK 0001833214

Entity typeother

Related Parties

1
  • filerCIK 0001937585

Filing Metadata

Form type
4
Filed
Sep 14, 8:00 PM ET
Accepted
Sep 15, 5:00 PM ET
Size
5.7 KB